Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
14.69
-0.37 (-2.46%)
Mar 6, 2026, 12:40 PM EST - Market open
Sotera Health Company Stock Forecast
Stock Price Forecast
The 6 analysts that cover Sotera Health Company stock have a consensus rating of "Buy" and an average price target of $20.67, which forecasts a 40.71% increase in the stock price over the next year. The lowest target is $16 and the highest is $24.
Price Target: $20.67 (+40.71%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sotera Health Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Hold | 1 | 1 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $21 → $23 | Strong Buy | Maintains | $21 → $23 | +56.57% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $24 | Buy | Initiates | $24 | +63.38% | Jan 9, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $17 → $24 | Hold → Buy | Upgrades | $17 → $24 | +63.38% | Jan 9, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 18, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $19 | Buy | Initiates | $19 | +29.34% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
1.25B
from 1.16B
Increased by 7.51%
Revenue Next Year
1.33B
from 1.25B
Increased by 6.00%
EPS This Year
0.97
from 0.27
Increased by 260.46%
EPS Next Year
1.06
from 0.97
Increased by 8.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.3B | 1.4B | ||
| Avg | 1.3B | 1.3B | ||
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.2% | 11.1% | ||
| Avg | 7.5% | 6.0% | ||
| Low | 3.6% | 1.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.03 | 1.13 | ||
| Avg | 0.97 | 1.06 | ||
| Low | 0.89 | 0.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 281.1% | 16.5% | ||
| Avg | 260.5% | 8.6% | ||
| Low | 230.3% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.